Keyword: Abbott

News

After Tech Success, Israel Seeks Life Sciences Growth

06.06.2013 - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...

News

Drug Industry CEOs Plotting More Carve-outs

07.05.2013 - A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new...

News

AbbVie Delivers on Scorching Humira Drug Sales Growth

26.04.2013 - AbbVie reported slightly better than expected quarterly results on Friday, fueled by surging sales of its Humira treatment for rheumatoid arthritis. Sales of Humira, which accounts...

News

Abbott Devices, Generics Struggle

17.04.2013 - Abbott Laboratories on Wednesday reported higher quarterly earnings after splitting off its branded drug business, and the company said demand was strong for its infant formulas...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

GlaxoSmithKline Unit Joins Patent Pool for AIDS Drugs

27.02.2013 - GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor...

News

AbbVie Forecasts Slower Humira Growth

31.01.2013 - AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories, forecast 2013 earnings in line with Wall Street forecasts but slowing sales growth for...

News

Abbott Results Bode Well for Spun-off AbbVie

24.01.2013 - AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...